USC Launches First-in-Human Trial of Cartilage-Protecting Knee Injection
Keck Medicine of USC has launched an early-phase clinical trial testing CX-011, a single-injection investigational therapy designed to modulate GP130 ...
Keck Medicine of USC has launched an early-phase clinical trial testing CX-011, a single-injection investigational therapy designed to modulate GP130 ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.